RPMGlobal Holdings Limited (ASX:RUL)

Intra-Cellular Therapies Revenue

RPMGlobal Holdings had revenue of 53.50M AUD in the half year ending December 31, 2024, with 26.28% growth. This brings the company's revenue in the last twelve months to 105.45M, up 9.03% year-over-year. In the fiscal year ending June 30, 2024, RPMGlobal Holdings had annual revenue of 100.46M with 10.92% growth.

• Revenue (ttm): 105.45M
• Revenue Growth: +9.03%
• P/S Ratio: 7.05
• Revenue / Employee: 383.46K
• Employees: 275
• Market Cap: 743.86M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	100.46M	9.89M	10.92%
Jun 30, 2023	90.57M	12.93M	16.65%
Jun 30, 2022	77.65M	14.38M	22.74%
Jun 30, 2021	63.26M	-3.70M	-5.52%
Jun 30, 2020	66.96M	-5.53M	-7.63%